Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Jul;234(1):116-21.
doi: 10.1097/00000658-200107000-00017.

Intravascular extension of Wilms tumor

Affiliations

Intravascular extension of Wilms tumor

R C Shamberger et al. Ann Surg. 2001 Jul.

Abstract

Objective: To define the incidence and manifestations of and optimal therapy for children with intravascular extension of Wilms tumor.

Methods: Children on a collaborative study of Wilms tumor who had intravascular extension into the inferior vena cava (IVC) or atrium were identified. Surgical checklists and surgical and pathology reports were reviewed.

Results: One hundred sixty-five of 2,731 patients had intravascular extension of Wilms tumor. The level of extension was IVC in 134 and atrium in 31. Sixty-nine had received preoperative therapy (55 with IVC extension and 14 with atrial extension) for a median of 8 weeks. Complications during preoperative chemotherapy were seen in five patients (tumor embolism and tumor progression in one each, and three with adult respiratory distress syndrome, one of which was fatal). The intravascular extension of the tumor regressed in 39 of 49 children with comparable pre- and posttherapy radiographic studies, including 7 of 12 in whom the tumor regressed from an atrial location, thus obviating the need for cardiopulmonary bypass. Surgical complications occurred in 36.7% of the children in the atrial group and 17.2% in the IVC group. The frequency of surgical complications was 26% in the primary resection group versus 13.2% in children with preoperative therapy. When all the complications of therapy were considered, including those that occurred during the interval of preoperative chemotherapy (one of the five also had a surgical complication), the incidence of complications among those receiving preoperative therapy was not statistically different from the incidence among those who underwent primary resection. The difference in 3-year relapse-free survival (76.9% for 165 patients with intravascular extension, 80.3% for 1,622 patients with no extension) was not statistically significant whether or not it was adjusted for stage and histology.

Conclusions: Preoperative treatment of these children may facilitate resection by decreasing the extent of the tumor thrombus, but the overall frequency of complications is similar in both groups.

PubMed Disclaimer

Figures

None
Figure 1. Kaplan-Meier relapse-free survival curves show no difference between children with or without vascular extension (P = .32).

References

    1. Green DM, Breslow NE, Beckwith JB, et al. Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol 1998; 16: 237–245. - PubMed
    1. Nakayama DK, DeLorimier AA, O’Neill JA Jr, et al. Intracardiac extension of Wilms’ tumor: a report of the National Wilms’ Tumor Study. Ann Surg 1986; 204: 693–697. - PMC - PubMed
    1. Ritchey ML, Kelalis PP, Breslow N, et al. Intracaval and atrial involvement with nephroblastoma: review of National Wilms’ Tumor Study 3. J Urol 1988; 140: 1113–1118. - PubMed
    1. Ritchey ML, Kelalis PP, Breslow N, et al. Surgical complications after nephrectomy for Wilms’ tumor. Surg Gynecol Obstet 1992; 175: 507–514. - PubMed
    1. Wagget J, Koop CE. Wilms’ tumor: preoperative radiotherapy and chemotherapy in the management of massive tumors. Cancer 1970; 26: 338–340. - PubMed

Publication types